Global Sustained Release Excipients Market Size study & Forecast, by Product (Gelatin, Polymers, Minerals, Sugars, Others) by Route of Administration (Oral, Intramuscular, Subcutaneous, Transdermal, Intravenous, Others), by Technology (Targeted Delivery,

Global Sustained Release Excipients Market Size study & Forecast, by Product (Gelatin, Polymers, Minerals, Sugars, Others) by Route of Administration (Oral, Intramuscular, Subcutaneous, Transdermal, Intravenous, Others), by Technology (Targeted Delivery, Microencapsulation, Wurster Technique, Others) and Regional Analysis, 2022-2029

Global Sustained Release Excipients Market is valued at approximately USD 1.19 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.22% over the forecast period 2022-2029. Sustained release excipients are a dosage form that is designed to release a drug slowly during a specific period to help in maintaining a constant drug concentration with minimum side effects. The growing need for pediatric and geriatric sustained release dosage forms and rising benefits of sustained release excipients compared to conventional dosage forms are acting as a major catalyzing factor for the market demand around the world.

The rising emphasis on the development of oral drug delivery technologies is because of improving drug therapeutic competence, along with bioavailability and patient compliance.

For instance, an article published in the National Center for Biotechnology Information (NCBI) on September 2021 stated the potential use of gastro retentive drug delivery techniques that maintain dose forms in the upper gastrointestinal tract. Thus, these technologies with sustained-release approaches offer better patient compliance and therapeutic effectiveness by decreasing dosing frequency, which, in turn, fuels the market demand in the global market. Furthermore, the growing focus on antibiotic resistance, as well as increasing acceptance owing to the nature of dosage forms are further factors that are leveraging the market opportunities in the forthcoming years. However, the chances of drug toxicity are associated due to dose dumping and the growing need for the high dose of API is restricting the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Sustained Release Excipients Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the space in terms of revenue, owing to the patent expirations and successive entry of generics, along with the growing investment in R&D activities. Whereas, the Asia Pacific is expected to grow significantly during the forecast period. Factors such as the increasing prevalence of various infectious diseases, the growing need for highly effective therapeutics, as well as rising establishment of production facilities, are burgeoning the market growth in the forecasting years.

Major market players included in this report are:
BASF SE
International Flavors & Fragrances, Inc.
Ashland Global
Evonik Industries
Croda International Plc
Gattefossé
Merck KGaA
Pfizer, Inc.
Sun Pharmaceutical Industries Ltd.
Mayne Pharma Group Limited

Recent Developments in the Market:
 In April 2019, Colorcon, Inc. declared that the company plans to expand its functional film coatings by including the Aquacoat range of modified release products via the Controlled Release Alliance with DuPont.
 In February 2021, DuPont successfully completed its merger with Nutrition & Biosciences Business for international flavors & fragrances. The addition of Aquacoat products into the portfolio enhances the range of solutions presented to fulfill the industry's requirement.

Global Sustained Release Excipients Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Route of Administration, Technology, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Gelatin
Polymers
Minerals
Sugars
Others
By Route of Administration:
Oral
Intramuscular
Subcutaneous
Transdermal
Intravenous
Others
By Technology:
Targeted Delivery
Microencapsulation
Wurster Technique
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Companies Mentioned

BASF SE
International Flavors & Fragrances, Inc.
Ashland Global
Evonik Industries
Croda International Plc
Gattefossé
Merck KGaA
Pfizer, Inc.
Sun Pharmaceutical Industries Ltd.
Mayne Pharma Group Limited

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.